Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Circulation: Arrhythmia and Electrophysiology. 2009;2:213-214
doi: 10.1161/CIRCEP.109.876904
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Havranek, E. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Havranek, E. P.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Health policy and outcome research
Right arrowRelated Article

Editorials

Atrial Fibrillation Through the Patient’s Eyes

Edward P. Havranek, MD

From the Denver Health Medical Center, University of Colorado Denver School of Medicine, Denver, Colo.

Correspondence to Edward P. Havranek, MD, 777 Bannock St, No. 0960, Denver, CO 80204-4507. E-mail ehavrane@dhha.org

Key Words: Editorials


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


    Introduction
 
The Canadian Cardiovascular Society Severity in Atrial Fibrillation (CCS-SAF) scale described in the report by Dorian et al1 in this issue of Circulation: Arrhythmia and Electrophysiology is worthy of our attention because it offers us something we can use. It also serves a deeper purpose and offers us something we should use.

Article see p 218

It is of use because it gives us a simple and reliable tool to use at the bedside to understand patients’ experiences with atrial fibrillation. We have scales that assess patient’s overall health status (so-called generic questionnaires), the most widely used of which is the SF-36 questionnaire. The SF-36 has been used previously to assess health status in a number of studies of atrial fibrillation.2 Its length, however, limits its use in everyday clinical practice. A shorter version (the SF-12) is available, but it is not clear if this questionnaire is able to separate the impact of atrial fibrillation from the burden of comorbidity that is the lot of the typical patient. We also have questionnaires specific for atrial fibrillation.3–5 Although they might be able to dissect the impact of atrial fibrillation from that of comorbidity, they have not been widely used and are too long for bedside use.

Scales useful at the bedside have characteristics in common. They combine data from a large enough number of variables to provide adequate discrimination yet from a small enough number of variables to allow commitment to memory—usually 3 to 5. The data are typically available from . . . [Full Text of this Article]


Related Article

Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale
Paul Dorian, Peter G. Guerra, Charles R. Kerr, Suzan S. O’Donnell, Eugene Crystal, Anne M. Gillis, L. Brent Mitchell, Denis Roy, Allan C. Skanes, M. Sarah Rose, and D. George Wyse
Circ Arrhythm Electrophysiol 2009 2: 218-224. [Abstract] [Full Text] [PDF]